Response Genetics, Inc
RGDXQ
$0.00
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Revenue | 3.79M | 4.08M | 4.47M | 4.28M | 3.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.79M | 4.08M | 4.47M | 4.28M | 3.89M |
| Cost of Revenue | 2.31M | 2.92M | 2.54M | 2.59M | 2.44M |
| Gross Profit | 1.48M | 1.15M | 1.92M | 1.70M | 1.46M |
| SG&A Expenses | 4.85M | 4.39M | 4.80M | 4.33M | 4.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.43M | 7.63M | 7.82M | 7.39M | 7.37M |
| Operating Income | -3.64M | -3.55M | -3.35M | -3.11M | -3.48M |
| Income Before Tax | -4.02M | -3.41M | -3.64M | -3.14M | -3.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.02M | -3.41M | -3.64M | -3.14M | -3.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.02M | -3.41M | -3.64M | -3.14M | -3.50M |
| EBIT | -3.64M | -3.55M | -3.35M | -3.11M | -3.48M |
| EBITDA | -3.45M | -3.35M | -3.15M | -2.89M | -3.27M |
| EPS Basic | -0.10 | -0.09 | -0.09 | -0.08 | -0.09 |
| Normalized Basic EPS | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 |
| EPS Diluted | -0.10 | -0.09 | -0.09 | -0.08 | -0.09 |
| Normalized Diluted EPS | -0.06 | -0.06 | -0.06 | -0.05 | -0.06 |
| Average Basic Shares Outstanding | 38.80M | 38.79M | 38.73M | 38.73M | 38.72M |
| Average Diluted Shares Outstanding | 38.80M | 38.79M | 38.73M | 38.73M | 38.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
